GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones ...
Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced the U.S. Food ...
(RTTNews) - Medtronic plc. (MDT) announced the U.S. Food and Drug Administration approval for the Simplera Sync sensor for use with the MiniMed 780G system. The MiniMed 780G system now offers more ...
MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily ...
Medtronic plc MDT recently achieved the CE Mark for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one continuous glucose monitor (CGM) that does not require any fingersticks or over ...
Medtronic has collected a European approval that allows it to combine its latest automated insulin pump with its newest glucose sensor for the first time. The CE mark covers the MiniMed 780G pump and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results